随着现代麻醉技术的革新及加速康复外科(enhanced recovery after surgery, ERAS)理念的深入,临床短小手术日益增多,选择合适的镇静药物是保证手术有效性和安全性的关键。然而,并没有研究能证实哪一种镇静药物具备应用于短小手术的绝对优势。瑞马唑仑是一种新型的超短效苯二氮卓类镇静药物,作用时间短于咪达唑仑和丙泊酚,并且对血流动力学及呼吸的影响较小。目前,它有望成为一种被广泛应用于程序性镇静的超短效药物。本文就瑞马唑仑的药物特点、药代动力学类型、与传统镇静药物对比的优势、对脑电图的影响、在短小内镜检查中的应用方面进行综述,为其更好的应用于临床提供理论支持。
With the innovation of modern anesthesia technology and the deepening of the concept of Enhanced Recovery after Surgery (ERAS), clinical short surgery is increasing, and the selection of appropriate sedatives is the key to ensure the effectiveness and safety of surgery. However, no study has proved which sedative has absolute advantage in short surgery. Remimazolam is a new type of ultra short acting benzodiazepine. Duration is shorter than midazolam and propofol, and less effect on the he-modynamics and breathing. Currently, it is expected to become a widely used ultra short-acting drug in procedural sedation. This article mainly reviews progress in Remimazolam’s mechanism of action, pharmacokinetics, advantages of remimazolam vs conventional sedatives. Effects on elec-troencephalography and application in short endoscopy provide theoretical basis for clinical appli-cation.
随着现代麻醉技术的革新及加速康复外科(enhanced recovery after surgery, ERAS)理念的深入,临床短小手术日益增多,选择合适的镇静药物是保证手术有效性和安全性的关键。然而,并没有研究能证实哪一种镇静药物具备应用于短小手术的绝对优势。瑞马唑仑是一种新型的超短效苯二氮卓类镇静药物,作用时间短于咪达唑仑和丙泊酚,并且对血流动力学及呼吸的影响较小。目前,它有望成为一种被广泛应用于程序性镇静的超短效药物。本文就瑞马唑仑的药物特点、药代动力学类型、与传统镇静药物对比的优势、对脑电图的影响、在短小内镜检查中的应用方面进行综述,为其更好的应用于临床提供理论支持。
关键词
镇静,丙泊酚,咪达唑仑,瑞马唑仑
Efficacy and Safety Profile of Remimazolam for Sedation in Short Surgical Procedures
Received: Apr. 27th, 2022; accepted: May 21st, 2022; published: May 31st, 2022
ABSTRACT
With the innovation of modern anesthesia technology and the deepening of the concept of Enhanced Recovery after Surgery (ERAS), clinical short surgery is increasing, and the selection of appropriate sedatives is the key to ensure the effectiveness and safety of surgery. However, no study has proved which sedative has absolute advantage in short surgery. Remimazolam is a new type of ultra short acting benzodiazepine. Duration is shorter than midazolam and propofol, and less effect on the hemodynamics and breathing. Currently, it is expected to become a widely used ultra short-acting drug in procedural sedation. This article mainly reviews progress in Remimazolam’s mechanism of action, pharmacokinetics, advantages of remimazolam vs conventional sedatives. Effects on electroencephalography and application in short endoscopy provide theoretical basis for clinical application.
吴馨婷,闫锦威,杨靖梅,王学军. 瑞马唑仑用于短时间手术镇静中有效性和安全性的研究Efficacy and Safety Profile of Remimazolam for Sedation in Short Surgical Procedures[J]. 临床医学进展, 2022, 12(05): 4783-4787. https://doi.org/10.12677/ACM.2022.125694
参考文献ReferencesSigel, E. and Buhr, A. (1997) The Benzodiazepine Binding Site of GABAA Receptors. Trends in Pharmacological Sci-ences, 18, 425-429. Erratum in: Trends in Pharmacological Sciences, 1998; 19: 256.
<br>https://doi.org/10.1016/S0165-6147(97)90675-1Wandel, C., Böcker, R., Böhrer, H., Browne, A., Rügheimer, E. and Martin, E. (1994) Midazolam Is Metabolized by at Least Three Different Cytochrome P450 Enzymes. British Journal of Anaesthesia, 73, 658-661.
<br>https://doi.org/10.1093/bja/73.5.658Sneyd, J.R. (2012) Remimazolam: New Beginnings or Just a Me-Too? Anesthesia and Analgesia, 115, 217-219.
<br>https://doi.org/10.1213/ANE.0b013e31823acb95Kilpatrik, G.J., Mclntyre, M.S., Cox, R.F., et al. (2007) CNS 7056: a Novel Ultra-Short-Acting Benzodiazepine. Anesthesiology, 107, 60-66. <br>https://doi.org/10.1097/01.anes.0000267503.85085.c0Antonik, L.J., Goldwater, D.R., Kilpatrick, G.J., et al. (2012) A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmaco-kinetics, and Pharmacodynamics of Remimazolam 8CNS 7056): Part I. Safety, Efficacy, and Basic Pharmacokinetics. Anesthesia and Analgesia, 115, 274-283.
<br>https://doi.org/10.1213/ANE.0b013e31823f0c28Schuttler, J., Eisenried, A., Lerch, M., et al. (2020) Pharma-cokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology, 132, 636-651. <br>https://doi.org/10.1097/ALN.0000000000003103Kanto, J.H. (1985) Midazolam: The First Water-Soluble Benzodiazepine. Pharmacology, Pharmacokinetics and Efficacy in Insomnia and Anesthesia. Pharmacotherapy, 5, 138-155. <br>https://doi.org/10.1002/j.1875-9114.1985.tb03411.xDoi, M., Morita, K., Takeda, J., et al. (2020) Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Parallel-Group, Phase IIb/III Trial. Journal of Anesthesia, 34, 545-553.
<br>https://doi.org/10.1007/s00540-020-02788-6Zhang, X., Li, S. and Liu, J. (2021) Efficacy and Safety of Remimazolam Besylate versus Propofol during Hysteroscopy: Single-Centre Randomized Controlled Trial. BMC Anes-thesiology, 21, Article No. 156.
<br>https://doi.org/10.1186/s12871-021-01373-yLee, H.C., Ryu, H.G., Park, Y., et al. (2019) Data Driven Inves-tigation of Bispectral Index Algorithm. Scientific Reports, 9, 13769-13778. <br>https://doi.org/10.1038/s41598-019-50391-xShi, D., Shen, C., Wu, J., et al. (2021) Evaluation of Prognosis of Coma Patients with Acute Brain Injury by Electroencephalogram Bispectral Index Monitoring. Journal of Trauma Nursing, 28, 298-303.
<br>https://doi.org/10.1097/JTN.0000000000000607Eisenried, A., Schuttler, J., Lerch, M., et al. (2020) Pharma-cokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part II. Pharmacokinetics of Electroencephalogram Effects. Anesthesiology, 132, 652-666. <br>https://doi.org/10.1097/ALN.0000000000003102Upton, R., Martinez, A. and Grant, C. (2008) A Dose Es-calation Study in Sheep of the Effects of the Benzodiazepine and the Respiratory and Cardiovascular Systems. British Journal of Pharmacology, 155, 52-61.
<br>https://doi.org/10.1038/bjp.2008.228Borkett, K.M.C., Riff, D.S., Schwartz, H.I., et al. (2015) A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) versus Midazolam for Sedation in Upper Gastrointesti-nal Endoscopy. Anesthesia and Analgesia, 120, 771-780. <br>https://doi.org/10.1213/ANE.0000000000000548Chen, S., Wang, J., Xu, X., et al. (2020) The Efficacy and Safety of Remimazolam Tosylate versus Propofol in Patients Undergoing Colonoscopy: A Multicentered, Randomized, Positive-Controlled, Phase III Clinical Trial. American Journal of Translational Research, 12, 4594-4603.Chen, S.H., Yuan, T.M., Zhang, J., et al. (2020) Remimazolam Tosilate in Upper Gastrointestinal Endoscopy: A Multicenter, Randomized, Non-Inferiority, Phase III Trial. Journal of Gastroenterology and Hepatology (Australia), 36, 474-481. <br>https://doi.org/10.1111/jgh.15188Pastis, N.J., Yarmus, L.B., Schippers, F., et al. (2019) Safety and Efficacy of Remimazolam Compared with Placebo and Midazolam for Moderate Sedation during Bronchoscopy. Chest, 155, 137-146.
<br>https://doi.org/10.1016/j.chest.2018.09.015